![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Rilpivirine population pharmacokinetic modeling in
antiretroviral-naïve, HIV-1-infected adolescents in PAINT
|
|
|
Reported by Jules Levin
16th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy, Washington, WA, USA, May 26-28 2015
Anne Brochot, Annemie Hoogstoel, Simon Vanveggel, Marita Stevens, Herta M Crauwels
Janssen Infectious Diseases BVBA, Beerse, Belgium
CROI/2014: Rilpivirine pharmacokinetics in HIV-1-infected adolescents:
a substudy of PAINT (Phase II trial).......http://www.natap.org/2014/CROI/croi_174.htm
![pharm1.gif](../images/060215/060215-3/pharm1.gif)
![pharm2.gif](../images/060215/060215-3/pharm2.gif)
![pharm3.gif](../images/060215/060215-3/pharm3.gif)
![pharm4.gif](../images/060215/060215-3/pharm4.gif)
![pharm5.gif](../images/060215/060215-3/pharm5.gif)
![pharm6.gif](../images/060215/060215-3/pharm6.gif)
![pharm7.gif](../images/060215/060215-3/pharm7.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|